Fusion Pharmaceuticals Inc.

Point72 Asset Management, L.P.

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

293,611

Value ($000)

2,822

Weight

0.0%

2020 Q2 - 2023 Q4 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	2,822	0.0%	293,611	12/31/2023
2023 Q3	11/14/2023	855	0.0%	328,868	9/30/2023
2023 Q2	8/14/2023	1,536	0.0%	328,868	6/30/2023
2023 Q1	5/15/2023	1,240	0.0%	328,868	3/31/2023
2022 Q4	5/15/2023	1,036	0.0%	328,868	12/31/2022
2022 Q3	11/14/2022	933	0.0%	310,068	9/30/2022
2022 Q2	8/15/2022	819	0.0%	328,868	6/30/2022
2022 Q1	5/16/2022	2,720	0.0%	350,000	3/31/2022
2021 Q4	2/14/2022	4,374	0.0%	1,048,956	12/31/2021
2021 Q3	11/15/2021	6,795	0.0%	858,012	9/30/2021
2021 Q2	8/16/2021	7,071	0.0%	875,141	6/30/2021
2021 Q1	5/17/2021	8,040	0.0%	750,000	3/31/2021
2020 Q4	2/16/2021	6,463	0.0%	550,000	12/31/2020
2020 Q2	8/14/2020	1,048	0.0%	60,000	6/30/2020